Similarly in the current study, there were potential synergistic effects between MAG and INR and between GLI and INR, on POD, which may further suggest that blood glucose change in patients with DM was associated with POD risk with the potential mechanism of metabolic disorders associated with changes in liver and kidney function. This evidence concerns the gene GLI1 and metabolic disease.